Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Oncogene ; 22(29): 4469-77, 2003 Jul 17.
Artigo em Inglês | MEDLINE | ID: mdl-12881703

RESUMO

Human papillomaviruses (HPV) are causative agents of human cancers including those of the cervix and also of the head and neck; HPV16 is the most commonly found type in these diseases. The viral E2 protein regulates transcription from the viral genome by interacting with DNA-binding sequences in the HPV transcriptional control region; it also regulates replication by interacting with and recruiting the HPV replication factor E1 to the viral origin. Therefore, E2 is essential for the viral life cycle. The E2 protein interacts with several proteins involved in the cellular response to DNA damage including p53, TopBP1, and PARP. We therefore set out to establish whether DNA-damaging agents can regulate E2 activity. Here we show that UVB irradiation downregulates transcriptional activity of both HPV16 and HPV8 E2, while hydroxyurea and etoposide do not. This downregulation of E2 activity is independent of p53 function as it occurs in p53 wild type and null cell types as well as in the presence of functional HPV16 E6 that degrades p53. Using stable cell lines expressing E2 we show that this downregulation of E2 function by UVB is due to a reduction of the E2 protein half-life. The identification of the pathway(s) through which UVB downregulates E2 transcriptional activity and protein levels will present a novel target for the treatment of HPV-related diseases.


Assuntos
Proteínas de Ligação a DNA , Proteínas Oncogênicas Virais/metabolismo , Ativação Transcricional/efeitos da radiação , Raios Ultravioleta , Antineoplásicos/farmacologia , Dano ao DNA , Regulação para Baixo/efeitos da radiação , Meia-Vida , Células HeLa , Humanos , Leupeptinas/farmacologia , Proteínas Oncogênicas Virais/efeitos dos fármacos , Proteínas Oncogênicas Virais/genética , Proteínas Oncogênicas Virais/efeitos da radiação , Transativadores/efeitos dos fármacos , Transativadores/metabolismo , Transativadores/efeitos da radiação , Células Tumorais Cultivadas , Proteína Supressora de Tumor p53/efeitos dos fármacos , Proteína Supressora de Tumor p53/metabolismo , Proteína Supressora de Tumor p53/efeitos da radiação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA